• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Digital Therapeutics Market

    ID: MRFR/Pharma/16404-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Digital Therapeutics Market Research Report By Application (Chronic Disease Management, Mental Health Disorders, Preventive Care, General Wellness), By Delivery Mode (Software, Device, Platform), By End User (Patients, Providers, Payers, Employers) and By Therapeutic Area (Diabetes, Cardiology, Neurology, Oncology) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Digital Therapeutics Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    US Digital Therapeutics Market Summary

    The US Digital Therapeutics market is poised for substantial growth, projected to reach 10.6 USD Billion by 2035 from 1.73 USD Billion in 2024.

    Key Market Trends & Highlights

    US Digital Therapeutics Key Trends and Highlights

    • The market is expected to grow from 1.73 USD Billion in 2024 to 10.6 USD Billion by 2035.
    • A compound annual growth rate (CAGR) of 17.87 percent is anticipated from 2025 to 2035.
    • The increasing prevalence of chronic diseases is likely to drive demand for digital therapeutic solutions.
    • Growing adoption of digital health technologies due to the rising need for personalized healthcare is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.73 (USD Billion)
    2035 Market Size 10.6 (USD Billion)
    CAGR (2025-2035) 17.87%

    Major Players

    MedRhythms, Pear Therapeutics, Omada Health, Lumiata, Myndshift, Dthera Sciences, WellDoc, Akili Interactive, Happify Health, Noom, Zebra Health, Big Health, Click Therapeutics, PsychoGenics

    US Digital Therapeutics Market Trends

    The US Digital Therapeutics Market is experiencing notable growth driven by an increasing prevalence of chronic diseases, such as diabetes and mental health disorders, which are becoming more prevalent in the population. The rise of telehealth solutions, accelerated by the COVID-19 pandemic, has further pushed demand for digital therapeutic interventions, as healthcare providers and patients seek remote management options.

    The awareness and acceptance of digital health solutions among healthcare professionals and patients are also key market drivers. Numerous states have begun integrating digital therapeutics into standard care protocols, highlighting a shift towards more technology-driven healthcare solutions.

    There are significant opportunities to be explored in the US Digital Therapeutics Market. The aging population offers a chance for the development of specific products targeting age-related health issues, such as cognitive decline and mobility problems. Furthermore, partnerships between tech firms and health organizations can lead to innovative solutions that further enhance user engagement.

    As more payers begin to recognize the efficacy of digital therapeutics, reimbursement policies are evolving to include these solutions, providing a clear pathway for widespread adoption. Recent trends indicate that collaboration among stakeholders in the healthcare ecosystem, including technology companies, pharmaceutical firms, and healthcare providers, is increasing.

    Innovations focus on personalized medicine, where digital therapies are tailored to individual patient profiles, enhancing effectiveness and user experience. Additionally, regulatory bodies are adapting to this market evolution by providing clearer guidance on the approval processes for digital therapeutics, which is crucial for fostering innovation while ensuring patient safety.

    Overall, these trends suggest a robust future for the digital therapeutics landscape in the US, shaped by technology, collaboration, and regulatory support.

    US Digital Therapeutics Market Drivers

    Market Segment Insights

    Digital Therapeutics Market Application Insights

    The US Digital Therapeutics Market is experiencing significant growth and evolution, particularly within the Application segment, which is crucial for addressing various health concerns through technology-enabled solutions. The Application segment can be categorized into different areas, including Chronic Disease Management, Mental Health Disorders, Preventive Care, and General Wellness, each of which plays a vital role in the healthcare landscape.

    Chronic Disease Management is increasingly regarded as a priority area where digital therapeutics offer patients innovative methods to manage conditions such as diabetes, hypertension, and cardiovascular diseases, allowing for real-time monitoring and personalized treatment without constantly relying on traditional healthcare settings. On the other hand, Mental Health Disorders encompass a broad spectrum of conditions, including anxiety and depression, which have reached alarming levels in the US.

    Digital therapeutics in this area aim to provide effective therapeutic interventions through mobile applications, fostering greater accessibility and reducing stigma associated with mental health treatment. Preventive Care is gaining traction as a proactive approach to health, utilizing digital health solutions to promote healthy lifestyles and prevent diseases before they become severe, thereby supporting long-term health improvements for the population.

    General Wellness encompasses a range of applications focused on improving overall health, promoting physical activities, enhancing nutrition, and improving sleep quality, which are essential components of holistic health. The increasing adoption of mobile health applications, coupled with advancements in technology, is driving the growth within these Application areas.

    Furthermore, the involvement of healthcare providers, insurers, and other stakeholders is becoming increasingly essential as they recognize the potential of digital therapeutics in facilitating patient engagement and improving treatment adherence. With the regulatory landscape becoming more supportive and the demand for remote health management continuing to rise, the prospects for each Application category within the US Digital Therapeutics Market are promising.

    Digital Therapeutics Market Delivery Mode Insights

    The Delivery Mode segment of the US Digital Therapeutics Market is crucial for enabling tailored healthcare solutions, focusing on the ways these therapeutics are made accessible to patients. This segment encompasses three primary channels: Software, Device, and Platform, each playing a significant role in enhancing patient engagement and treatment adherence.

    Software solutions typically offer mobile applications and web-based systems that facilitate real-time monitoring and therapeutic interventions, enhancing user experience and supporting chronic disease management. Devices, which include wearables and other hardware, provide critical data collection and feedback mechanisms that empower users to take charge of their health, thus fostering patient participation and compliance with therapy regimens.

    Platforms serve as comprehensive ecosystems that integrate software and devices, streamlining workflows for healthcare providers while ensuring that patients receive consistent, personalized care. The continued evolution and adoption of these delivery modes are driven by the increasing demand for remote healthcare solutions and the emphasis on chronic disease management within the US healthcare landscape, illustrating the significance of this segment in advancing healthcare outcomes.

    Digital Therapeutics Market End User Insights

    The US Digital Therapeutics Market exhibits a diverse End User landscape consisting of Patients, Providers, Payers, and Employers, each playing a pivotal role in the industry's growth. Patients represent a substantial segment as they increasingly adopt digital health solutions for managing chronic conditions, which significantly enhances treatment adherence and outcomes.

    Providers, including physicians and healthcare institutions, are instrumental in integrating these solutions into standard care practices, driven by a demand for innovative therapies that improve patient engagement and result in better clinical outcomes. Payers, such as insurance companies, are adapting their frameworks to cover digital therapeutics, recognizing their potential to reduce overall healthcare costs by promoting preventive care and reducing hospital admissions.

    Employers are also showing a keen interest in digital therapeutics as they seek to provide additional health benefits to their employees, which can lead to improved workforce health and productivity. This multi-faceted engagement among the End User categories signifies a growing recognition of the value of digital therapeutics in addressing healthcare challenges and improving access to innovative treatment options in the US.

    Digital Therapeutics Market Therapeutic Area Insights

    The US Digital Therapeutics Market focusing on the Therapeutic Area segment is characterized by significant advancements, driven by increasing adoption of technology in healthcare and the rising prevalence of chronic diseases. The Diabetes sector is notably important as it addresses the growing number of individuals managing this condition, offering personalized treatment solutions that enhance patient engagement and outcomes.

    Similarly, the Cardiology area holds a vital role due to the escalating rates of heart disease in the US, where digital therapies can provide patients with real-time monitoring and management tools. In Neurology, digital therapeutics are crucial in managing complex conditions such as epilepsy and multiple sclerosis, complementing traditional therapies with innovative solutions that can improve cognition and quality of life.

    Meanwhile, Oncology is emerging as a significant segment, as digital therapeutics aid in symptom management, adherence to treatment, and emotional support for patients undergoing cancer therapies. With a robust focus on personalized care and preventive strategies, the Therapeutic Area within the US Digital Therapeutics Market is poised for growth, buoyed by ongoing technological advancements and increased health awareness.

    This market showcases a blend of high demand for tailored therapeutic solutions and the opportunity for greater patient outcomes through digital innovation.

    Get more detailed insights about US Digital Therapeutics Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The US Digital Therapeutics Market has emerged as a dynamic and rapidly evolving sector within the broader healthcare landscape, driven by technological advancements and an increasing recognition of the importance of patient-centric care. As digital solutions increasingly take center stage, numerous companies are competing to offer innovative therapeutic interventions that leverage software to treat various medical conditions, from mental health disorders to chronic diseases.

    Notable players in this market are differentiating themselves through unique digital offerings, regulatory approvals, and collaborations with healthcare providers. The competitive insights reveal a trend towards partnerships and a focus on clinically validated programs that transition traditional therapeutic methodologies into digital platforms, catering to both patients and healthcare systems.

    MedRhythms

    MedRhythms has established a commendable presence within the US Digital Therapeutics Market, focusing on innovative therapeutic solutions utilizing music and rhythm-based interventions to address neurological conditions. The company's strengths lie in its evidence-based approach, having developed clinically validated products aimed at improving functions such as walking and mobility in patients with neurological diseases.

    MedRhythms actively collaborates with various stakeholders in the healthcare ecosystem, including research institutions and healthcare providers, to enhance its offerings and ensure compliance with regulatory standards. The company’s unique positioning in the market helps it garner attention from healthcare professionals who seek alternative therapeutic approaches for patients requiring progressive rehabilitation solutions.

    Pear Therapeutics

    Pear Therapeutics has also made significant strides in the US Digital Therapeutics Market with its commitment to developing prescription digital therapeutics that address a range of conditions, including substance use disorder and other behavioral health issues. The company boasts a robust portfolio of products that are clinically validated and prescribed by healthcare professionals as adjuncts to standard therapies.

    Pear Therapeutics has established strategic partnerships and collaborations that have amplified its market reach and enhanced its service offerings, aligning itself with leading healthcare providers and payers. Notably, the company has engaged in mergers and acquisitions to bolster its technological capabilities and expand its product pipeline, positioning itself as a leader in this rapidly evolving space.

    With a focus on regulatory compliance and evidence-based solutions, Pear Therapeutics is actively contributing to the development of digital therapies that seamlessly integrate into existing treatment paradigms for patients across the United States.

    Key Companies in the US Digital Therapeutics Market market include

    Industry Developments

    Recent developments in the US Digital Therapeutics Market have showcased a growing momentum among key players such as MedRhythms, Pear Therapeutics, and Omada Health, particularly in the wake of increased regulatory support and rising demand post-pandemic. In September 2023, Dthera Sciences announced updates to their product offerings aimed at enhancing mental health interventions, emphasizing the market's focus on behavioral health solutions.

    Additionally, in August 2023, WellDoc launched a new version of its diabetes management platform, contributing to increased awareness among healthcare providers. Notable acquisitions include Akili Interactive's acquisition of a digital therapeutics platform in July 2023, enhancing their cognitive behavioral therapy offerings.

    Pear Therapeutics experienced a valuation increase following a funding round that attracted significant investment. The US Digital Therapeutics Market is projected to grow considerably as healthcare systems integrate these technologies into traditional treatment plans, fostering collaboration across various sectors.

    The expansion in digital health tools has resulted in a shift in therapeutic approaches, with companies like Noom and Happify Health gaining traction by focusing on holistic health solutions. The regulatory landscape continues to evolve, providing clarity and support for innovative therapeutic solutions in the realm of mental health and chronic disease management.

    Market Segmentation

    Digital Therapeutics Market End User Outlook

    • Patients
    • Providers
    • Payers
    • Employers

    Digital Therapeutics Market Application Outlook

    • Chronic Disease Management
    • Mental Health Disorders
    • Preventive Care
    • General Wellness

    Digital Therapeutics Market Delivery Mode Outlook

    • Software
    • Device
    • Platform

    Digital Therapeutics Market Therapeutic Area Outlook

    • Diabetes
    • Cardiology
    • Neurology
    • Oncology

    Report Scope

     

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 1.48(USD Billion)
    MARKET SIZE 2024 1.73(USD Billion)
    MARKET SIZE 2035 10.56(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 17.887% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED MedRhythms, Pear Therapeutics, Omada Health, Lumiata, Myndshift, Dthera Sciences, WellDoc, Akili Interactive, Happify Health, Noom, Zebra Health, Big Health, Click Therapeutics, PsychoGenics
    SEGMENTS COVERED Application, Delivery Mode, End User, Therapeutic Area
    KEY MARKET OPPORTUNITIES Chronic disease management solutions, Behavioral health support platforms, Remote patient monitoring tools, Integration with telehealth services, Personalized treatment pathways
    KEY MARKET DYNAMICS Regulatory approvals, Rising chronic diseases, Increased funding, Growing consumer adoption, Integration with traditional care
    COUNTRIES COVERED US

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the US Digital Therapeutics Market in 2024?

    The US Digital Therapeutics Market is expected to be valued at 1.73 billion USD in 2024.

    What is the anticipated market size for the US Digital Therapeutics Market by 2035?

    By 2035, the US Digital Therapeutics Market is projected to reach 10.56 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Digital Therapeutics Market from 2025 to 2035?

    The expected CAGR for the US Digital Therapeutics Market from 2025 to 2035 is 17.887 percent.

    Which application segment accounts for the largest market size in the US Digital Therapeutics Market in 2024?

    Chronic Disease Management is the largest application segment, valued at 0.69 billion USD in 2024.

    What will be the market size for the Mental Health Disorders application segment by 2035?

    The Mental Health Disorders segment is projected to grow to 3.14 billion USD by 2035.

    Which are the key players in the US Digital Therapeutics Market?

    Major players include MedRhythms, Pear Therapeutics, Omada Health, and Akili Interactive among others.

    What is the market value for Preventive Care in the US Digital Therapeutics Market in 2024?

    Preventive Care is valued at 0.29 billion USD in 2024 within the US Digital Therapeutics Market.

    How large is the General Wellness segment projected to be by 2035?

    The General Wellness segment is expected to reach 1.45 billion USD by 2035.

    What growth drivers are influencing the US Digital Therapeutics Market?

    Advancements in technology and a growing emphasis on preventive healthcare are driving market growth.

    What challenges might impact the growth of the US Digital Therapeutics Market?

    Regulatory hurdles and varying reimbursement policies could pose challenges to market expansion.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. US
    59. Digital Therapeutics Market, BY Application (USD Billion)
    60. Chronic
    61. Disease Management
    62. Mental Health Disorders
    63. Preventive
    64. Care
    65. General Wellness
    66. US
    67. Digital Therapeutics Market, BY Delivery Mode (USD Billion)
    68. Software
    69. Device
    70. Platform
    71. US
    72. Digital Therapeutics Market, BY End User (USD Billion)
    73. Patients
    74. Providers
    75. Payers
    76. Employers
    77. US
    78. Digital Therapeutics Market, BY Therapeutic Area (USD Billion)
    79. Diabetes
    80. Cardiology
    81. Neurology
    82. Oncology
    83. Competitive Landscape
    84. Overview
    85. Competitive
    86. Analysis
    87. Market share Analysis
    88. Major
    89. Growth Strategy in the Digital Therapeutics Market
    90. Competitive
    91. Benchmarking
    92. Leading Players in Terms of Number of Developments
    93. in the Digital Therapeutics Market
    94. Key developments and
    95. growth strategies
    96. New Product Launch/Service Deployment
    97. Merger
    98. & Acquisitions
    99. Joint Ventures
    100. Major
    101. Players Financial Matrix
    102. Sales and Operating Income
    103. Major
    104. Players R&D Expenditure. 2023
    105. Company
    106. Profiles
    107. MedRhythms
    108. Financial
    109. Overview
    110. Products Offered
    111. Key
    112. Developments
    113. SWOT Analysis
    114. Key
    115. Strategies
    116. Pear Therapeutics
    117. Financial
    118. Overview
    119. Products Offered
    120. Key
    121. Developments
    122. SWOT Analysis
    123. Key
    124. Strategies
    125. Omada Health
    126. Financial
    127. Overview
    128. Products Offered
    129. Key
    130. Developments
    131. SWOT Analysis
    132. Key
    133. Strategies
    134. Lumiata
    135. Financial
    136. Overview
    137. Products Offered
    138. Key
    139. Developments
    140. SWOT Analysis
    141. Key
    142. Strategies
    143. Myndshift
    144. Financial
    145. Overview
    146. Products Offered
    147. Key
    148. Developments
    149. SWOT Analysis
    150. Key
    151. Strategies
    152. Dthera Sciences
    153. Financial
    154. Overview
    155. Products Offered
    156. Key
    157. Developments
    158. SWOT Analysis
    159. Key
    160. Strategies
    161. WellDoc
    162. Financial
    163. Overview
    164. Products Offered
    165. Key
    166. Developments
    167. SWOT Analysis
    168. Key
    169. Strategies
    170. Akili Interactive
    171. Financial
    172. Overview
    173. Products Offered
    174. Key
    175. Developments
    176. SWOT Analysis
    177. Key
    178. Strategies
    179. Happify Health
    180. Financial
    181. Overview
    182. Products Offered
    183. Key
    184. Developments
    185. SWOT Analysis
    186. Key
    187. Strategies
    188. Noom
    189. Financial
    190. Overview
    191. Products Offered
    192. Key
    193. Developments
    194. SWOT Analysis
    195. Key
    196. Strategies
    197. Zebra Health
    198. Financial
    199. Overview
    200. Products Offered
    201. Key
    202. Developments
    203. SWOT Analysis
    204. Key
    205. Strategies
    206. Big Health
    207. Financial
    208. Overview
    209. Products Offered
    210. Key
    211. Developments
    212. SWOT Analysis
    213. Key
    214. Strategies
    215. Click Therapeutics
    216. Financial
    217. Overview
    218. Products Offered
    219. Key
    220. Developments
    221. SWOT Analysis
    222. Key
    223. Strategies
    224. PsychoGenics
    225. Financial
    226. Overview
    227. Products Offered
    228. Key
    229. Developments
    230. SWOT Analysis
    231. Key
    232. Strategies
    233. References
    234. Related
    235. Reports
    236. LIST
    237. OF ASSUMPTIONS
    238. US Digital Therapeutics Market SIZE ESTIMATES
    239. & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    240. US
    241. Digital Therapeutics Market SIZE ESTIMATES & FORECAST, BY DELIVERY MODE, 2019-2035
    242. (USD Billions)
    243. US Digital Therapeutics Market SIZE ESTIMATES
    244. & FORECAST, BY END USER, 2019-2035 (USD Billions)
    245. US
    246. Digital Therapeutics Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA,
    247. 2035 (USD Billions)
    248. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    249. ACQUISITION/PARTNERSHIP
    250. LIST
    251. Of figures
    252. MARKET SYNOPSIS
    253. US
    254. DIGITAL THERAPEUTICS MARKET ANALYSIS BY APPLICATION
    255. US
    256. DIGITAL THERAPEUTICS MARKET ANALYSIS BY DELIVERY MODE
    257. US
    258. DIGITAL THERAPEUTICS MARKET ANALYSIS BY END USER
    259. US DIGITAL
    260. THERAPEUTICS MARKET ANALYSIS BY THERAPEUTIC AREA
    261. KEY
    262. BUYING CRITERIA OF DIGITAL THERAPEUTICS MARKET
    263. RESEARCH
    264. PROCESS OF MRFR
    265. DRO ANALYSIS OF DIGITAL THERAPEUTICS
    266. MARKET
    267. DRIVERS IMPACT ANALYSIS: DIGITAL THERAPEUTICS
    268. MARKET
    269. RESTRAINTS IMPACT ANALYSIS: DIGITAL THERAPEUTICS
    270. MARKET
    271. SUPPLY / VALUE CHAIN: DIGITAL THERAPEUTICS MARKET
    272. DIGITAL
    273. THERAPEUTICS MARKET, BY APPLICATION, 2025 (% SHARE)
    274. DIGITAL
    275. THERAPEUTICS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    276. DIGITAL
    277. THERAPEUTICS MARKET, BY DELIVERY MODE, 2025 (% SHARE)
    278. DIGITAL
    279. THERAPEUTICS MARKET, BY DELIVERY MODE, 2019 TO 2035 (USD Billions)
    280. DIGITAL
    281. THERAPEUTICS MARKET, BY END USER, 2025 (% SHARE)
    282. DIGITAL
    283. THERAPEUTICS MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    284. DIGITAL
    285. THERAPEUTICS MARKET, BY THERAPEUTIC AREA, 2025 (% SHARE)
    286. DIGITAL
    287. THERAPEUTICS MARKET, BY THERAPEUTIC AREA, 2019 TO 2035 (USD Billions)
    288. BENCHMARKING
    289. OF MAJOR COMPETITORS

    US Digital Therapeutics Market Segmentation

     

    • Digital Therapeutics Market By Application (USD Billion, 2019-2035)

      • Chronic Disease Management
      • Mental Health Disorders
      • Preventive Care
      • General Wellness

     

    • Digital Therapeutics Market By Delivery Mode (USD Billion, 2019-2035)

      • Software
      • Device
      • Platform

     

    • Digital Therapeutics Market By End User (USD Billion, 2019-2035)

      • Patients
      • Providers
      • Payers
      • Employers

     

    • Digital Therapeutics Market By Therapeutic Area (USD Billion, 2019-2035)

      • Diabetes
      • Cardiology
      • Neurology
      • Oncology

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027